OTCMKTS:DDXS

Diadexus Stock Forecast, Price & News

Add

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 30 shs
Average Volume: 15,481 shs
Market Capitalization: $53 thousand

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Receive DDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for Diadexus and its competitors with MarketBeat's FREE daily newsletter.

About Diadexus

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

Diadexus, Inc. to File Chapter 7
October 26, 2021 | finance.yahoo.com

Luka Doncic and Zion Williamson both post career highs in points as Mavericks win
February 13, 2021 | msn.com

Caleb Plant vs. Caleb Truax betting preview: How to bet on super middleweight title bout
January 29, 2021 | msn.com

Bet $1 on any NBA game tonight and win $100 in free bets to use toward the big game next Sunday
January 29, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Health Technology
Current Symbol: OTCMKTS:DDXS
Previous Symbol
CUSIP: 25245P106
CIK: 1036968
Web: www.diadexus.com
Phone: (650) 246-6400
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 4,100,000
Free Float: N/A
Market Cap: $53 thousand
Optionable: Not Optionable

Company Calendar

Last Earnings: 10/26/2015
Today: 12/09/2021

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Diadexus.

4.5 Community Rank

Outperform Votes
Diadexus has received 137 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Diadexus has received 65 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Diadexus has received 67.82% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Diadexus and other stocks. Vote “Outperform” if you believe DDXS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DDXS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Diadexus does not currently pay a dividend.
Dividend Growth
Diadexus does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Diadexus insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Diadexus (OTCMKTS:DDXS) Frequently Asked Questions

How were Diadexus' earnings last quarter?: Diadexus, Inc. (OTCMKTS:DDXS) released its earnings results on Monday, October, 26th. The company reported ($0.34) EPS for the quarter, beating the Zacks' consensus estimate of ($0.69) by $0.35.
View Diadexus' earnings history.
Who are Diadexus' key executives?: Diadexus' management team includes the following people:
Kenneth Charles Fang, Chief Medical Officer
Amy Figueroa, Head-Investor Relations
Who are some of Diadexus' key competitors?: Some companies that are related to Diadexus include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), ALK-Abello A/S (AKBLF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX) and Anatara Lifesciences (ANR).
View all of DDXS's competitors.
What other stocks do shareholders of Diadexus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Diadexus investors own include GoPro (GPRO), General Electric (GE), Ambarella (AMBA) and Alliqua Biomedical (ALQA).
What is Diadexus' stock symbol?: Diadexus trades on the OTCMKTS under the ticker symbol "DDXS."
How do I buy shares of Diadexus?: Shares of DDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How much money does Diadexus make?: Diadexus has a market capitalization of $0.00.
What is Diadexus' official website?: The official website for Diadexus is www.diadexus.com.
Where are Diadexus' headquarters?: Diadexus is headquartered at 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States.
How can I contact Diadexus?: Diadexus' mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at (650) 246-6400.

This page was last updated on 12/9/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Diadexus Stock Forecast, Price & News

About Diadexus

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.5 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

0.0 Earnings and Valuation

Diadexus (OTCMKTS:DDXS) Frequently Asked Questions

How were Diadexus' earnings last quarter?

Who are Diadexus' key executives?

Who are some of Diadexus' key competitors?

What other stocks do shareholders of Diadexus own?

What is Diadexus' stock symbol?

How do I buy shares of Diadexus?

How much money does Diadexus make?

What is Diadexus' official website?

Where are Diadexus' headquarters?

How can I contact Diadexus?